Hot Sale Thalidomide-o-acetamido-peg3-c2-azide Perfect Gift [CxMGNoV2]

Hot Sale Thalidomide-o-acetamido-peg3-c2-azide Perfect Gift [CxMGNoV2]: A Versatile Building Block for Targeted Protein Degradation

Hot Sale Thalidomide-o-acetamido-peg3-c2-azide Perfect Gift [CxMGNoV2] is a highly effective degrader building block designed for targeted protein degradation. This innovative compound is tailored to facilitate the development of novel therapeutic strategies in the field of protein degradation. Its core features include an E3 ligase ligand, a linker, and a functional group, which can be easily conjugated to target protein ligands through straightforward chemical reactions. This unique design allows for precise and efficient degradation of specific proteins, making it an invaluable tool in drug discovery and development.

Product Specifications and Technical Details

Hot Sale Thalidomide-o-acetamido-peg3-c2-azide Perfect Gift [CxMGNoV2] boasts a molecular formula of C23H28N6O9 and a molecular weight of 532.51. The product is offered with a purity of >= 95% (HPLC), ensuring high-quality and reliable performance. It is also supplied in a convenient form for easy handling and integration into various research applications. Key specifications include a CAS number of 2402790-58-1 and a shipping condition of room temperature. For storage, it is recommended to keep the product refrigerated to maintain its stability and shelf life, which is 12 months after the date of delivery. The regulatory statement for this product is "For Research Use Only," underscoring its specialized application in the laboratory setting.

Applications and Benefits in Targeted Protein Degradation

Hot Sale Thalidomide-o-acetamido-peg3-c2-azide Perfect Gift [CxMGNoV2] is an essential component for researchers and scientists working in the field of targeted protein degradation. Its versatility and ease of use make it an ideal choice for various applications, including the development of novel therapeutic agents for diseases such as cancer, neurodegenerative disorders, and genetic diseases. The product's ability to conjugate to target protein ligands simplifies the process of identifying and degrading specific proteins, leading to more effective and targeted therapies. By utilizing this building block, researchers can explore new avenues in drug discovery and advance the development of innovative treatments for a wide range of diseases.